Cargando…

Elimination of HIV-1-infected cells by broadly neutralizing antibodies

The Fc region of HIV-1 Env-specific broadly neutralizing antibodies (bNAbs) is required for suppressing viraemia, through mechanisms which remain poorly understood. Here, we identify bNAbs that exert antibody-dependent cellular cytotoxicity (ADCC) in cell culture and kill HIV-1-infected lymphocytes...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruel, Timothée, Guivel-Benhassine, Florence, Amraoui, Sonia, Malbec, Marine, Richard, Léa, Bourdic, Katia, Donahue, Daniel Aaron, Lorin, Valérie, Casartelli, Nicoletta, Noël, Nicolas, Lambotte, Olivier, Mouquet, Hugo, Schwartz, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782064/
https://www.ncbi.nlm.nih.gov/pubmed/26936020
http://dx.doi.org/10.1038/ncomms10844
_version_ 1782419887808839680
author Bruel, Timothée
Guivel-Benhassine, Florence
Amraoui, Sonia
Malbec, Marine
Richard, Léa
Bourdic, Katia
Donahue, Daniel Aaron
Lorin, Valérie
Casartelli, Nicoletta
Noël, Nicolas
Lambotte, Olivier
Mouquet, Hugo
Schwartz, Olivier
author_facet Bruel, Timothée
Guivel-Benhassine, Florence
Amraoui, Sonia
Malbec, Marine
Richard, Léa
Bourdic, Katia
Donahue, Daniel Aaron
Lorin, Valérie
Casartelli, Nicoletta
Noël, Nicolas
Lambotte, Olivier
Mouquet, Hugo
Schwartz, Olivier
author_sort Bruel, Timothée
collection PubMed
description The Fc region of HIV-1 Env-specific broadly neutralizing antibodies (bNAbs) is required for suppressing viraemia, through mechanisms which remain poorly understood. Here, we identify bNAbs that exert antibody-dependent cellular cytotoxicity (ADCC) in cell culture and kill HIV-1-infected lymphocytes through natural killer (NK) engagement. These antibodies target the CD4-binding site, the glycans/V3 and V1/V2 loops on gp120, or the gp41 moiety. The landscape of Env epitope exposure at the surface and the sensitivity of infected cells to ADCC vary considerably between viral strains. Efficient ADCC requires sustained cell surface binding of bNAbs to Env, and combining bNAbs allows a potent killing activity. Furthermore, reactivated infected cells from HIV-positive individuals expose heterogeneous Env epitope patterns, with levels that are often but not always sufficient to trigger killing by bNAbs. Our study delineates the parameters controlling ADCC activity of bNAbs, and supports the use of the most potent antibodies to clear the viral reservoir.
format Online
Article
Text
id pubmed-4782064
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47820642016-03-15 Elimination of HIV-1-infected cells by broadly neutralizing antibodies Bruel, Timothée Guivel-Benhassine, Florence Amraoui, Sonia Malbec, Marine Richard, Léa Bourdic, Katia Donahue, Daniel Aaron Lorin, Valérie Casartelli, Nicoletta Noël, Nicolas Lambotte, Olivier Mouquet, Hugo Schwartz, Olivier Nat Commun Article The Fc region of HIV-1 Env-specific broadly neutralizing antibodies (bNAbs) is required for suppressing viraemia, through mechanisms which remain poorly understood. Here, we identify bNAbs that exert antibody-dependent cellular cytotoxicity (ADCC) in cell culture and kill HIV-1-infected lymphocytes through natural killer (NK) engagement. These antibodies target the CD4-binding site, the glycans/V3 and V1/V2 loops on gp120, or the gp41 moiety. The landscape of Env epitope exposure at the surface and the sensitivity of infected cells to ADCC vary considerably between viral strains. Efficient ADCC requires sustained cell surface binding of bNAbs to Env, and combining bNAbs allows a potent killing activity. Furthermore, reactivated infected cells from HIV-positive individuals expose heterogeneous Env epitope patterns, with levels that are often but not always sufficient to trigger killing by bNAbs. Our study delineates the parameters controlling ADCC activity of bNAbs, and supports the use of the most potent antibodies to clear the viral reservoir. Nature Publishing Group 2016-03-03 /pmc/articles/PMC4782064/ /pubmed/26936020 http://dx.doi.org/10.1038/ncomms10844 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Bruel, Timothée
Guivel-Benhassine, Florence
Amraoui, Sonia
Malbec, Marine
Richard, Léa
Bourdic, Katia
Donahue, Daniel Aaron
Lorin, Valérie
Casartelli, Nicoletta
Noël, Nicolas
Lambotte, Olivier
Mouquet, Hugo
Schwartz, Olivier
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
title Elimination of HIV-1-infected cells by broadly neutralizing antibodies
title_full Elimination of HIV-1-infected cells by broadly neutralizing antibodies
title_fullStr Elimination of HIV-1-infected cells by broadly neutralizing antibodies
title_full_unstemmed Elimination of HIV-1-infected cells by broadly neutralizing antibodies
title_short Elimination of HIV-1-infected cells by broadly neutralizing antibodies
title_sort elimination of hiv-1-infected cells by broadly neutralizing antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782064/
https://www.ncbi.nlm.nih.gov/pubmed/26936020
http://dx.doi.org/10.1038/ncomms10844
work_keys_str_mv AT brueltimothee eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT guivelbenhassineflorence eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT amraouisonia eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT malbecmarine eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT richardlea eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT bourdickatia eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT donahuedanielaaron eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT lorinvalerie eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT casartellinicoletta eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT noelnicolas eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT lambotteolivier eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT mouquethugo eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies
AT schwartzolivier eliminationofhiv1infectedcellsbybroadlyneutralizingantibodies